Full-Life Technologies signs for $16 million loan as part of series B

Chicago, Jan. 3 – Full-Life Technologies Ltd. borrowed a new $16 million loan facility, secured with its series B equity financing, according to a press release.

Prosperity7 Ventures, Sky9 Capital, Summer Capital, and GuanghuaWutong Fund, as well as existing shareholders Chengwei Capital, HongShan, and Junson Capital provided the $47.3 million series B equity financing raise.

Proceeds will be used for the company’s pipeline development and construction of the radiopharmaceutical manufacturing plant in Belgium.

Full-Life Technologies is a fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.